Albers Jeffrey W.
- SEC CIK
- 0001638474
In the past year, 3 open-market sale filings worth $3.15M and no purchases.
Current role at each company
- SYRE Spyre Therapeutics, Inc.Directoras of Aug 10, 2026
- KYMR Kymera Therapeutics, Inc.Directoras of Jun 25, 2026
- BPMC Blueprint Medicines CorpDirectoras of Jul 21, 2025
- DNTH Dianthus Therapeutics, Inc.Directoras of Jun 30, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.15M
- 3 filings
- Net
- −$3.15M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Albers Jeffrey W. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SYRE Spyre Therapeutics, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)9:31 PM ET | Aug 7 | 3 days | Albers Jeffrey W.Director | SSale | −5.00K | $104.47 | −$522.4K | −100.0%0 after | 10b5-1 |
| Aug 10, 2026 (view filing)9:31 PM ET | Aug 7 | 3 days | Albers Jeffrey W.Director | SSale | −18.0K | $104.55 | −$1.88M | −65.8%9.36K after | 2 lots10b5-1 |
| Nov 8, 2024 (view filing) | Nov 6 | 2 days | Albers Jeffrey W.Director | SSale | −6.70K | $36.76 | −$246.3K | −19.7%27.4K after | 10b5-1 |
| Oct 28, 2024 (view filing) | Oct 25 | 3 days | Albers Jeffrey W.Director | SSale | −300 | $36.43 | −$10.9K | −0.9%34.1K after | 10b5-1 |
KYMR Kymera Therapeutics, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 (view filing) | Dec 8 | Same day | Albers Jeffrey W.Director | SSale | −5.00K | $89.76 | −$448.8K | −100.0%0 after | 2 lots10b5-1 |
| Oct 14, 2025 (view filing) | Oct 13 | 1 day | Albers Jeffrey W.Director | SSale | −5.00K | $59.19 | −$295.9K | −100.0%0 after | 10b5-1 |
| Jun 3, 2025 (view filing) | Jun 3 | Same day | Albers Jeffrey W.Director | SSale | −6.35K | $49.00 | −$311.1K | −100.0%0 after | 10b5-1 |
| Aug 26, 2024 (view filing) | Aug 26 | Same day | Albers Jeffrey W.Director | SSale | −5.00K | $49.10 | −$245.5K | −100.0%0 after | 10b5-1 |
| Feb 21, 2024 (view filing) | Feb 20-21 | 1 day | Albers Jeffrey W.Director | SSale | −5.00K | $39.05 | −$195.3K | −100.0%0 after | 2 lots10b5-1 |
| Jan 23, 2024 (view filing) | Jan 23 | Same day | Albers Jeffrey W.Director | SSale | −10.0K | $30.05 | −$300.5K | −100.0%0 after | 10b5-1 |
BPMC Blueprint Medicines Corp
Director28 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 (view filing) | May 27 | 2 days | Albers Jeffrey W.Director | SSale | −5.00K | $101.14 | −$505.7K | −3.3%146.6K after | 2 lots10b5-1 |
| Mar 17, 2025 (view filing) | Mar 5 | 12 daysLate | Albers Jeffrey W.Director | SSale | −5.77K | $88.80 | −$512.0K | −3.8%146.6K after | |
| Mar 14, 2025 (view filing) | Mar 12 | 2 days | Albers Jeffrey W.Director | SSale | −7.50K | $87.80 | −$658.5K | −4.7%152.4K after | 2 lots10b5-1 |
| Jan 23, 2025 (view filing) | Jan 21 | 2 days | Albers Jeffrey W.Director | SSale | −15.2K | $109.53 | −$1.66M | −9.0%152.4K after | 3 lots10b5-1 |
| Jan 15, 2025 (view filing) | Jan 13 | 2 days | Albers Jeffrey W.Director | SSale | −5.00K | $102.28 | −$511.4K | −3.1%157.6K after | 10b5-1 |
| Dec 20, 2024 (view filing) | Dec 19 | 1 day | Albers Jeffrey W.Director | SSale | −15.0K | $89.77 | −$1.35M | −8.7%157.6K after | 4 lots10b5-1 |
| Nov 12, 2024 (view filing) | Nov 7 | 5 days | Albers Jeffrey W.Director | SSale | −5.00K | $102.00 | −$510.0K | −3.1%157.6K after | 10b5-1 |
| Sep 11, 2024 (view filing) | Sep 9 | 2 days | Albers Jeffrey W.Director | SSale | −19.7K | $85.57 | −$1.69M | −11.1%157.6K after | 2 lots10b5-1 |
| Mar 26, 2024 (view filing) | Mar 7 | 19 daysLate | Albers Jeffrey W.Director | SSale | −11.0K | $90.69 | −$1.00M | −6.3%165.0K after | |
| Mar 22, 2024 (view filing) | Mar 20 | 2 days | Albers Jeffrey W.Director | SSale | −25.1K | $87.28 | −$2.19M | −12.5%176.1K after | 5 lots10b5-1 |